203 related articles for article (PubMed ID: 1708400)
21. Diarylsulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
McMahon JB; Gulakowski RJ; Weislow OS; Schultz RJ; Narayanan VL; Clanton DJ; Pedemonte R; Wassmundt FW; Buckheit RW; Decker WD
Antimicrob Agents Chemother; 1993 Apr; 37(4):754-60. PubMed ID: 7684215
[TBL] [Abstract][Full Text] [Related]
22. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.
De Clercq E; Yamamoto N; Pauwels R; Baba M; Schols D; Nakashima H; Balzarini J; Debyser Z; Murrer BA; Schwartz D
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5286-90. PubMed ID: 1608936
[TBL] [Abstract][Full Text] [Related]
23. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.
Witvrouw M; Fikkert V; Pluymers W; Matthews B; Mardel K; Schols D; Raff J; Debyser Z; De Clercq E; Holan G; Pannecouque C
Mol Pharmacol; 2000 Nov; 58(5):1100-8. PubMed ID: 11040059
[TBL] [Abstract][Full Text] [Related]
24. Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus.
Ichimura H; Levy JA
Virology; 1995 Aug; 211(2):554-60. PubMed ID: 7544050
[TBL] [Abstract][Full Text] [Related]
25. Potent and selective inhibition of human immunodeficiency virus type 1 (HIV-1) by 5-ethyl-6-phenylthiouracil derivatives through their interaction with the HIV-1 reverse transcriptase.
Baba M; De Clercq E; Tanaka H; Ubasawa M; Takashima H; Sekiya K; Nitta I; Umezu K; Nakashima H; Mori S
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2356-60. PubMed ID: 1706522
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of HIV-1 replication in H9 cells by nystatin-A compared with other antiviral agents.
Selvam MP; Blay RA; Geyer S; Buck SM; Pollock L; Mayner RE; Epstein JS
AIDS Res Hum Retroviruses; 1993 May; 9(5):475-81. PubMed ID: 7686387
[TBL] [Abstract][Full Text] [Related]
27. Novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 8. 8-Aryloxymethyl- and 8-arylthiomethyldipyridodiazepinones.
Cywin CL; Klunder JM; Hoermann M; Brickwood JR; David E; Grob PM; Schwartz R; Pauletti D; Barringer KJ; Shih CK; Sorge CL; Erickson DA; Joseph DP; Hattox SE
J Med Chem; 1998 Jul; 41(16):2972-84. PubMed ID: 9685236
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of human immunodeficiency virus type 1 replication by 7-methyl-6,8-bis(methylthio)pyrrolo[1,2-a]pyrazine, an in vivo metabolite of oltipraz.
Prochaska HJ; Bornmann WG; Baron P; Polsky B
Mol Pharmacol; 1995 Jul; 48(1):15-20. PubMed ID: 7542738
[TBL] [Abstract][Full Text] [Related]
29. (-)-2'-deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro.
Coates JA; Cammack N; Jenkinson HJ; Jowett AJ; Jowett MI; Pearson BA; Penn CR; Rouse PL; Viner KC; Cameron JM
Antimicrob Agents Chemother; 1992 Apr; 36(4):733-9. PubMed ID: 1380229
[TBL] [Abstract][Full Text] [Related]
30. Novel naphthalenedisulfonic acid anti-HIV-1 agents. Synthesis and activity against reverse transcriptase, virus replication and syncytia formation.
Mohan P; Singh R; Baba M
Drug Des Discov; 1991 Nov; 8(1):69-82. PubMed ID: 1725723
[TBL] [Abstract][Full Text] [Related]
31. Incorporation of 12-methoxydodecanoate into the human immunodeficiency virus 1 gag polyprotein precursor inhibits its proteolytic processing and virus production in a chronically infected human lymphoid cell line.
Bryant ML; Ratner L; Duronio RJ; Kishore NS; Devadas B; Adams SP; Gordon JI
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2055-9. PubMed ID: 2006142
[TBL] [Abstract][Full Text] [Related]
32. Complete inhibition of viral breakthrough by combination of MKC-442 with AZT during a long-term culture of HIV-1 infected cells.
Okamoto M; Makino M; Yamada K; Nakade K; Yuasa S; Baba M
Antiviral Res; 1996 Jun; 31(1-2):69-77. PubMed ID: 8793010
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of human immunodeficiency virus replication by RD6-Y664, a novel benzylhydroxylamine derivative.
Okamoto M; Fujiwara M; Kodama E; Yamamoto O; Shigeta S; Mitsuya H; Konno K; Yokota T; Baba M
Antivir Chem Chemother; 1999 Mar; 10(2):71-7. PubMed ID: 10335401
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by daphnodorins.
Yusa K; Oh-hara T; Tsukahara S; Baba K; Taniguchi M; Kozawa M; Takeuchi S; Hara H; Tsuruo T
Antiviral Res; 1994 Sep; 25(1):57-66. PubMed ID: 7529015
[TBL] [Abstract][Full Text] [Related]
35. An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives.
Debyser Z; Pauwels R; Andries K; Desmyter J; Kukla M; Janssen PA; De Clercq E
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1451-5. PubMed ID: 1705038
[TBL] [Abstract][Full Text] [Related]
36. Activity of triciribine and triciribine-5'-monophosphate against human immunodeficiency virus types 1 and 2.
Kucera LS; Iyer NP; Puckett SH; Buckheit RW; Westbrook L; Toyer BR; White EL; Germany-Decker JM; Shannon WM; Chen RC
AIDS Res Hum Retroviruses; 1993 Apr; 9(4):307-14. PubMed ID: 7685612
[TBL] [Abstract][Full Text] [Related]
37. Resistance to 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives is generated by mutations at multiple sites in the HIV-1 reverse transcriptase.
Buckheit RW; Fliakas-Boltz V; Yeagy-Bargo S; Weislow O; Mayers DL; Boyer PL; Hughes SH; Pan BC; Chu SH; Bader JP
Virology; 1995 Jun; 210(1):186-93. PubMed ID: 7540784
[TBL] [Abstract][Full Text] [Related]
38. Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infection.
Lambert DM; Bartus H; Fernandez AV; Bratby-Anders C; Leary JJ; Dreyer GB; Metcalf BW; Petteway SR
Antiviral Res; 1993 Aug; 21(4):327-42. PubMed ID: 7692816
[TBL] [Abstract][Full Text] [Related]
39. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
Chow YK; Hirsch MS; Merrill DP; Bechtel LJ; Eron JJ; Kaplan JC; D'Aquila RT
Nature; 1993 Feb; 361(6413):650-4. PubMed ID: 7679778
[TBL] [Abstract][Full Text] [Related]
40. Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus.
Mao C; Sudbeck EA; Venkatachalam TK; Uckun FM
Antivir Chem Chemother; 1999 Sep; 10(5):233-40. PubMed ID: 10574178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
